Rare diseases
Investigational molecules
Locations
Study of Tucatinib, Trastuzumab, and mFOLFOX6 for Patients with HER2+ Metastatic Colorectal Cancer
The NetherlandsStudy on the Use of SYN2, Adenosine, and Regadenoson for Diagnosing Coronary Artery Disease in Patients with Suspected Heart Conditions
The NetherlandsStudy on the Effectiveness and Safety of Deucravacitinib for Adults with Active Sjogren's Syndrome
The NetherlandsStudy on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors
The NetherlandsStudy on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis
The NetherlandsStudy on the Safety and Effectiveness of Dazucorilant for Patients with Amyotrophic Lateral Sclerosis (ALS)
The NetherlandsStudy of LY3537982, pembrolizumab, and a drug combination for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
The NetherlandsStudy on the Safety and Effectiveness of GSK5733584 with Dostarlimab and Carboplatin for Patients with Advanced Gynecological Tumors
The NetherlandsA Study of Baricitinib to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes
The NetherlandsA Study of Baricitinib to Delay Type 1 Diabetes in Children and Adults at Risk of Developing the Disease
The NetherlandsAdjuvant Therapy with RO7435846 (divarasib) versus Pembrolizumab or Nivolumab or Observation in Patients After Surgery for Stage II‑III KRAS G12C NSCLC
The NetherlandsPhase III trial evaluating ianalumab with background drug combination in patients with Sjögren's disease
The NetherlandsTell us about your condition – we search every trial in Europe and connect you with the right site.
